drugset / Trial / NCT00922467

Influence of Esmolol on a Closed-Loop Anesthesia System

NCT00922467

Phase 3 Terminated 15 enrolled Hopital Foch
RandomizedParallel-groupTriple-blindTreatment

Summary

Main objective is to evaluate the sparing effect of esmolol on the required doses of propofol and remifentanil

Timeline

Start
2009-06
Primary completion
2009-12
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Esmolol Other / unclassified 0.2 mg/kg

Indications

No indication recorded.